一种新型DHA复合物的抑瘤作用及对Caspase-3凋亡蛋白表达的影响

目的评价一种新型DHA复合物（AT-158）对荷瘤小鼠移植瘤及体外培养肿瘤细胞的抑瘤作用,并对其可能的作用机制做初步探讨。方法建立移植瘤荷瘤小鼠动物模型和体外细胞培养的方法,评价AT-158在体内和体外的抑瘤作用,观察体外培养的Hela细胞在药物作用下的核形态的改变,测定移植瘤中Caspase-3凋亡蛋白表达的变化。结果AT-158在体内和体外均显示显著的抑瘤作用。肿瘤细胞的核形态发生凋亡细胞特征性改变。诱导凋亡执行蛋白Caspase-3表达增加。结论AT-158显示一定的抑瘤效果,具有较高的开发价值。     

雷丸菌核与发酵菌丝蛋白体外抑瘤对比分析

目的:研究雷丸发酵菌丝与菌核蛋白体外对肿瘤细胞HepG2的抑制作用.方法:分别提取雷丸菌核与发酵菌丝蛋白,进行体外抑瘤试验,记录细胞形态变化,计算抑瘤率,分析两者在抑瘤效果上的差异.结果:两种提取蛋白在体外对HepG2肿瘤细胞的抑制作用相近,最高可达80%左右.结论:发酵菌丝蛋白具有显著抑瘤作用,在深入研究药理毒理的基础上可替代菌核入药.     

抑瘤素M cDNA的克隆及表达

抑瘤素M(Oncostatin M,OSM)是一种多功能的细胞生长调节因子。从PMA刺激后的U937细胞系提取总RNA,采用逆转录-PCR方法分离到了抑瘤素M的cDNA;将抑瘤素M的cDNA克隆到质粒pUC19中,筛选3个阳性克隆进行序列分析,与国外报道序列完全一致;将抑瘤素M的cDNA克隆到质粒pBV220后再转化大肠杆菌DH5α进行模拟表达,SDS-PAGB分析表明有OSM表达,表达量约占细菌总蛋白的5％;经过初步纯化的OSM能明显抑制A375细胞的生长。     

抑瘤素McDNA的克隆及表达研究

抑瘤素M（onecostatinM,OSM）是一种多功能的细胞生长调节因子．从PMA刺激后的U937细胞系提取总RNA,采用逆转录-PCR方法分离到了抑瘤素M的cDNA;将抑瘤素M的cDNA克隆到质粒pUC19中,筛选三个阳性克隆进行序列分析,与国外报导序列完全一致;将抑癌素M的cDNA克隆到质粒pBV220后再转化DH5a进行模拟表达,SDS-PAGE分析表明有OSM表达,表达量约占细菌总蛋白5％,经过初步纯化的OSM能明显抑制A375细胞的生长．     

抑瘤素M cDNA的克隆及表达研究

抑瘤素Ｍ是一种我功能的细胞生长调节因子,从ＰＭＡ刺激后的Ｕ９３７细胞系提取总ＲＮＡ,采用逆转录－ＰＣＲ方法分离到了抑瘤素Ｍ的ＣＤＮＡ;将抑瘤素Ｍ的ＣＤＮＡ克隆到质粒ＰＵＣ１９中,筛选三个阳性克隆进行序列分析,与国外报导序列完全一致;将抑瘤素Ｍ的ＣＤＮＡ克隆到质粒ＰＢＶ２２０后再转化ＤＨ５α进行模拟表达,ＳＤＳ－ＰＡＧＥ分析表明有ＯＳＭ表达,表达量约占细菌总蛋白５％,经过初步纯化的ＯＳＭ能明显抑制Ａ     

低分子抑瘤物净化白血病细胞的实验研究及临床应用

胎儿肝脏中存在一类小分子量（分子量〈１０ｋＤ）的肿瘤抑制物,其在体外对ＨＬ－６０等多种白血病细胞系具有明显的选择性抑制作用,对急性白血病患者骨髓的白血病祖细胞也具有这种选择性抑制效果;分离纯化获得两种天然低分子抑瘤物（７－ＫＣ和７－β－ＨＣ）和一种外源性低分子抑瘤物（ＤＢＰ）,研究证实其抑制白血病细胞生长的作用机制是诱导白血病细胞凋亡;将其应用于白血病及恶性淋巴瘤自体骨髓移植时的体外净化,完成１２     

人胎肝细胞分泌的低分子抑瘤物对白血病细胞的抑制作用

本工作证明了在胎儿组织中存在一类低分子天然肿瘤抑制物,它是胎儿组织细胞生成和分泌的,对瘤株细胞和原代白血病细胞有选择性抑制作用。初发期或复发期急性非淋巴细胞白血病患者的骨髓在体外液体培养条件下与肝细胞上清及其甲醇提取物共同孵育4d,可使所有病例的骨髓AML—CFU降低到不可检出的程度。因而,低分子天然抑瘤物是天然肿瘤免疫中的一个组成部分,它在肿瘤的诊断和治疗中有着深远的意义。     

新城疫病毒FMW株体外溶瘤作用及其机制分析

[目的]筛选出能高效抑制多种人肿瘤细胞生长增殖的新城疫(New Castle disease virus,NDV)毒株,为进一步构建重组高效靶向溶瘤毒株奠定基础.[方法]以体外噻唑蓝法测定NDV对A549、SMMC7721等肿瘤细胞及人胚干细胞L-02、人胚肾细胞HEK293等的生长抑制率,空斑试验确定病毒滴度及感染复数.利用形态学观察、Hoechst荧光染色、流式细胞术及免疫印迹等分析了NDV-FMW诱导肿瘤细胞凋亡的细胞生物学变化及其机制.[结果]从近50株NDV中筛选出NDV-FMW,以20 MOI病毒作用A549、SMMC7721等肿瘤细胞48 h,细胞生长抑制率达60%,NDV-FMW诱导肿瘤细胞发生凋亡,效应呈时间和剂量的依赖性,凋亡细胞出现核染色质断裂、浓缩及二倍体亚峰,细胞周期阻滞于GO/G1期,此外,病毒感染A549细胞16 h后开始检测到活化的Caspase-3裂解片段及PARP裂解大片段.[结论]NDV-FMW株体外能高效抑制肿瘤细胞的增殖,并经Caspase-3途径诱导肿瘤细胞凋亡.FMW株具有自主知识产权,其良好的体外溶瘤能力为进一步探讨体内抗肿瘤及临床试验的进行奠定了基础,并有可能为恶性肿瘤的治疗提供新的生物制剂.     

蛇毒复合酶对人胃癌细胞的抑瘤研究

目的 观察蛇毒复合酶对人胃癌细胞SGC－7901的抑瘤作用及机理。方法 采用体外试验、流式细胞术和细胞形态学检查方法,观察人胃癌细胞的生长抑制率,以及细胞周期和细胞形态的变化。结果 蛇毒复合酶对人胃癌细胞有明显的抑瘤作用。24h抑瘤率达67．5％,接近5－Fu阳性对照组,并且具有明显的时效和量效关系。细胞镜检及涂片染色发现癌细胞胞膜破裂、胞质外溢、细胞坏死。流式细胞术检测蛇毒复合酶对S期细胞有明显杀伤作用,同时阻滞G0／G1期细胞进入S期。结论 蛇毒复合酶对人胃癌细胞具有一定体外抑瘤作用,其作用机理与直接破坏细胞胞膜和干扰细胞增殖周期有关。     

金荞麦Fr4的抑瘤作用研究

目的研究金荞麦的有效成份Fr4的抑瘤和对环磷酰胺(CTX)的协同抑瘤作用.方法采用小鼠移植瘤S-180、肝癌模型,观察Fr4的体内抑瘤作用.结果200,400,800mg@kg-1@d-1ip给药7天,对S-180移植瘤的抑制率为15.76%～24.80%,29.56%～55.84%,32.77～38.52%,Fr4200mg@kg-1@d-1与CTX20 mg@kg-1@d-1合用抑制率达37%～56.27%.结论Fr4具有抑瘤活性,与CTX合用有协同抑瘤作用.     

Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas

The expression of oncostatin M and leukemia inhibitory factor (LIF), JAK-STAT activators and members of the interleukin-6 family of cytokines, were examined in a series of primary ovarian carcinomas using immunohistochemistry. The malignant epithelial cells of all 29 ovarian carcinomas examined expressed oncostatin M; none expressed LIF. Oncostatin M can activate two related receptors, one consisting of a low-affinity LIF receptor subunit, LIFR beta, which forms a heterocomplex with the gp130 signal transducing protein and can recognize both oncostatin M and LIF, and a second heterocomplex consisting of a subunit that specifically recognizes oncostatin M, OSMR beta, and the gp130 protein. By immunohistochemistry, 25 of 25 ovarian carcinomas examined expressed the LIFR beta subunit in the malignant epithelial cells (all samples express gp130), and two-thirds the ovarian carcinomas studied expressed OSMR beta mRNA as determined by RT-PCR. Thus oncostatin M and its receptors are commonly coexpressed in malignant ovarian epithelial cells, and represent a potential autocrine loop in this tumor type. STAT3, of one the signaling proteins downstream of the oncostatin M/LIF receptors, was found in its phosphorylated, activated form (phosphotyrosine 705 STAT3) in the malignant epithelial cells of 17 of 23 ovarian carcinomas examined (74%) as determined by immunohistochemistry; this suggests that this protein is constitutively activated in most ovarian carcinomas, as it is in many other human malignancies. Recombinant human Oncostatin M (rhOSM) can induce the transient tyrosine 705 phosphorylation of STAT3 in serum-starved LIFR beta/OSMR beta expressing ovarian carcinoma cell lines, but does not alter cell growth and effects only a modest increase in the apoptotic rate in these cultured cells. Oncostatin M and its receptors may be part of a network of cytokine systems within ovarian carcinomas that may act to maintain STAT3 in its activated form, a phenomenon associated with the malignant phenotype.     

Purification of a novel growth inhibitory factor for partially differentiated myeloid leukemic cells

A novel factor termed growth inhibitory (GI) factor, which specifically inhibits the growth of mouse monocytic leukemia cells including monocytic cell lines (Mm-A and J774.1) and other partially differentiated myeloid leukemic cells, has been purified from conditioned medium of some clones of mouse myeloblastic leukemia M1 cells. The procedure for purification of the GI factor included ammonium sulfate precipitation, CM-Sepharose CL-6B and Sephadex G-200 chromatographies, reverse-phase high-performance liquid chromatography on a C18 hydrophobic support, and high-performance liquid chromatography on a gel filtration column. The purified factor gave a single band of protein with a molecular weight of 25,000 on sodium dodecyl sulfate-polyacrylamide gel. A concentration of 8 X 10(-10) M GI factor was required for 50% inhibition of growth of Mm-A cells. On chromatofocusing, the GI activity was eluted with Polybuffer 96/acetic acid at pH 8.2-8.4. The purified GI factor markedly inhibited growth of mouse bone marrow cells stimulated by macrophage colony-stimulating factor. The GI factor appeared to be a unique cytokine unrelated to known cytokines such as the tumor necrosis factor, interferons, and oncostatin M.     

Oncostatin M regulates mesenchymal cell differentiation and enhances hematopoietic supportive activity of bone marrow stromal cell lines

Bone marrow stromal cell lines (TBR cell lines) established from temperature-sensitive Simian Virus 40 T-antigen gene transgenic mice exhibited myogenic, osteogenic, and adipogenic differentiation. The effect of oncostatin M (OSM) on such mesenchymal cell differentiation of marrow stromal cell lines was examined. One of those stromal cell lines, TBRB, differentiated into skeletal muscle, and its differentiation was stimulated by OSM, whereas differentiation of TBR10-1 into smooth muscle was inhibited by OSM. TBR31-2 is a bipotent progenitor for adipocytes and osteoblasts, and OSM stimulated osteogenic differentiation while inhibiting adipogenic differentiation. On the other hand, TBR cell lines exhibited various potentials for supporting hematopoiesis in culture. When hematopoietic progenitor cells were cocultured with OSM-stimulated stromal cell lines, TBR10-1 and TBR31-2 exhibited enhanced hematopoietic supportive activity. As responsible molecules for stromal cell dependent hematopoiesis, expression of stem cell factor (SCF) (a ligand of c-Kit), vascular cell adhesion molecule (VCAM-1) (a ligand of VLA-4), and secretion of interleukin (IL)-6 were increased by OSM. OSM affected mesenchymal cell differentiation and promoted the hematopoietic supportive activity of marrow stromal cell lines. As OSM production is induced by cytokines from hematopoietic cells, OSM may be a key factor in mutual regulation between hematopoietic cells and stromal cells in the bone marrow. OSM may play a role as a regulator in maintaining the hematopoietic microenvironment in marrow by coordinating mesenchymal differentiation.     

细胞因子基因导入人肿瘤细胞的方法及鉴定

从人外周血单核细胞中抽提总RNA为模板,分别用5’含EcoRⅠ、3’含BamHⅠ限制性酶切位点的细胞因子基因特异引物合成合信号肽全长IL－2、γ－IFN及α－TNFcDNA．然后将这些细胞因子cDNA分别重组入含筛选标记基因Neo的逆转录病毒载体LXSN中．采用磷酸钙共沉淀法转染逆转录病毒包装细胞系PA317．分别收集到含IFN－γ、TNF－α和IL－2基因的缺陷型逆转录病毒上清及只具空白载体质粒pLXSN的病毒上清这四种病毒颗粒用于导入人肝癌、胃癌细胞,可获得单克隆化的细胞因子基因修饰株PCR,Southern,RT－PCR及Northern杂交证明,有相应细胞因子及筛选标记基因的转入和表达生物活性分析也证实各基因修饰株细胞培养上清液中有一定活性的相应细胞因子．结果表明逆转录病毒介导的细胞因子基因转移是成功的     

Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells.

Recent evidence suggests the possibility that macrophages can influence lipoprotein metabolism. Therefore we investigated the ability of cultured macrophages to alter low density lipoprotein (LDL) uptake in a human liver cell line (HepG2). Conditioned media from phlogogenic-induced mouse peritoneal macrophages or from a human macrophage cell line stimulated with endotoxin increased HepG2 LDL uptake by as much as 60-70%. The increase was due, in part, to a significant macrophage-induced 40% increase in the number of LDL receptors per cell. Although macrophage conditioned media inhibited HepG2 cholesterol synthesis, the LDL receptor up-regulation did not appear to be due to the effects on cholesterol synthesis. The LDL receptor stimulatory activity was sensitive to proteolysis and heat. Its molecular mass was approximately 20 kDa based on gel filtration. Several macrophage secretory proteins were tested in HepG2 cultures for LDL uptake stimulation. Of these, oncostatin M (approximately 18 kDa by gel filtration) gave the strongest response. The rank order for LDL uptake stimulation was oncostatin M much greater than interleukin 6 = interleukin 1 = transforming growth factor-beta 1. A neutralizing antibody directed against oncostatin M inhibited the ability of conditioned media to up-regulate LDL receptors by 85%. Thus, our results indicate that macrophages can secrete several proteins that up-regulate LDL receptors in HepG2 cells and that most of the up-regulatory activity in macrophage conditioned media appears to be due to oncostatin M.     

Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 Protein

The bone marrow stroma consists of a heterogeneous population of cells which participate in osteogenic, adipogenic, and hematopoietic events. The murine stromal cell line, BMS2, exhibits the adipocytic and osteoblastic phenotypes in vitro. BMS2 differentiation was examined in response to cytokines which share the gp130 signal transducing protein within their receptor complex. Four of the cytokines (interleukin 6, interleukin 11, leukemia inhibitory factor, and oncostatin M) inhibited hydrocortisone-induced adipocyte differentiation in a dose dependent manner based on lipid accumulation and lipoprotein lipase enzyme activity. Inhibition occurred only when the cytokines were present during the initial 24 h of the induction period; after 48 h, their effects were diminished. Likewise, these cytokines increased alkaline phosphatase enzyme activity twofold in preadipocyte BMS2 cells. Both leukemia inhibitory factor and oncostatin M induced early active gene expression in resting preadipocyte BMS2 cells and decreased the steady state mRNA level of a unique osteoblastic gene marker, osteocalcin. A fifth cytokine whose receptor complex shares the gp130 protein, ciliary neurotrophic factor, did not significantly regulate stromal cell differentiation when added by itself. However, with the addition of a missing component of its receptor complex, ciliary neurotrophic factor receptor α protein, this cytokine also inhibited BMS2 adipogenesis. Together, these data indicate that the cytokines whose receptors share the gp130 protein can modulate stromal cell commitment to the adipocyte and osteoblast differentiation pathways.     

Cysteine protease production by human osteosarcoma cells (MG63, SAOS2) and its modulation by soluble factors

The production of cysteine protease by two human osteosarcoma cell lines (MG-63 and SaOS2) was analyzed, as well as their modulation by interleukin 1beta (hIL-1 beta), interleukin 6 (hIL-6), insulin growth factor-1 (hIGF-1), oncostatin M (hOSM), leukemia inhibitory factor (hLIF) and growth hormone (hGH). Cysteine protease activities were detected using a synthetic substrate. The protease activities (especially cathepsin L activity) of both cell lines were increased significantly in the presence of hIL-1 beta, hIL-6 and hOSM. In contrast, hIGF-1 and hGH decreased these activities, and no effect was detectable in the presence of hLIF. The addition of antibodies against the gp-130 chain of the hIL-6 and hOSM receptors totally inhibited the stimulating effect of these two cytokines on cysteine protease activities. In increasing collagen type I degradation, hIL-1beta, hIL-6 and hOSM could be involved in bone resorption, whereas the inhibitory action of hIGF-1 and hGH on collagen type I degradation suggest that this factor could play a role in bone formation.     

Caveolin-1抑制胰腺癌细胞PANC1的体内外生长和增殖

窖蛋白-1(caveolin-1)是胞膜窖(caveolae)中重要的结构和功能蛋白.Caveolin-1参与细胞的多种生命活动并与恶性肿瘤的发生相关.为探讨caveolin-1对胰腺癌细胞PANC1的体外增殖、迁移、侵袭以及裸鼠体内成瘤能力的影响,通过基因转染技术培育caveolin-1过表达细胞株PANC1/cav-1作为实验组,转染空载体细胞株PANC1/vector作为对照组,采用RT-PCR及Western blot方法检测caveolin-1的表达量,流式细胞术分析细胞周期,软琼脂细胞克隆实验检测细胞增殖能力,侵袭小室实验检测癌细胞迁移和侵袭的能力,建立裸鼠皮下种植瘤模型并检测肿瘤组织的增殖与凋亡.PANC1/cav-1中的caveolin-1表达稳定,表达量明显高于对照组细胞株和亲本细胞株(P<0.01),细胞周期检测显示大量PANC1/cav-1细胞被抑制于G0/G1期,caveolin-1抑制PANC1的增殖,迁移和侵袭能力.在裸鼠的体内实验中,caveolin-1显著抑制PANC1细胞在裸鼠体内的生长,Ki-67染色和TUNEL染色表明在PANC1细胞中过表达caveolin-1,可以抑制肿瘤增殖并诱导肿瘤凋亡.上述结果表明,caveolin-1可能通过对胰腺癌细胞周期的影响(抑制于G0/G1期),抑制胰腺癌PANC1细胞在体内外的增殖、迁移和侵袭,并导致肿瘤凋亡.